good luck here. i agree on indx but im not playing that one. i only saw easy money here, this company is burning way to much cash,insiders selling so fast for any price and nobody wants the company. been for sale for along time and was ran up becasue bmy bought another bio. now at the 3-4 range its a gamble for a buyer if they had a phase 3 about to be approved and was better than a placebo run but here its just an empty shell company
Also agree with all this, except the placebo thing you keep mentioning. Results i have seen for ACH-1625 PI and their NS5A, etc are good and better than placebo. Have you seen something different or heard leaks about results not yet made public?